Structure of the receptor binding domain of EnvP(b)1, an endogenous retroviral envelope protein expressed in human tissues by McCarthy, Kevin R et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
11-17-2020 
Structure of the receptor binding domain of EnvP(b)1, an 
endogenous retroviral envelope protein expressed in human 
tissues 
Kevin R McCarthy 




See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Authors 
Kevin R McCarthy, Joseph L Timpona, Simon Jenni, Louis-Marie Bloyet, Vesna Brusic, Welkin E Johnson, 
Sean P J Whelan, and Lindsey R Robinson-McCarthy 
Structure of the Receptor Binding Domain of EnvP(b)1, an
Endogenous Retroviral Envelope Protein Expressed in Human
Tissues
Kevin R. McCarthy,a,b Joseph L. Timpona,c,d Simon Jenni,a Louis-Marie Bloyet,e Vesna Brusic,c Welkin E. Johnson,f
Sean P. J. Whelan,c,e Lindsey R. Robinson-McCarthyc,g
aDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA
bLaboratory of Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA
cDepartment of Microbiology, Harvard Medical School, Boston, Massachusetts, USA
dDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado, USA
eDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA
fDepartment of Biology, Boston College, Chestnut Hill, Massachusetts, USA
gDepartment of Genetics, Harvard Medical School, Boston, Massachusetts, USA
Kevin R. McCarthy and Joseph L. Timpona contributed equally to this work. Author order was decided based on contributions to the manuscript.
ABSTRACT EnvP(b)1 is an endogenous retroviral envelope gene found in human
and other primate genomes. We report EnvP(b)1 sequences in primate genomes
consistent with an integration event between 40 and 71 million years ago. Using a
highly specific polyclonal antiserum raised against the putative receptor binding do-
main (RBD) of human EnvP(b)1, we detected expression in human placenta, ovaries,
and thymus. We found that EnvP(b)1 is proteolytically processed, and using cell-cell
fusion assays in multiple primate cell lines, we demonstrated that extant EnvP(b)1
proteins from a variety of primate genomes are fusogenic. This work supports the
idea that EnvP(b)1 is under purifying selection and its fusogenic activity has been
maintained for over 40 million years. We determined the structure of the RBD of hu-
man EnvP(b)1, which defines structural similarities with extant leukemia viruses, de-
spite little sequence conservation. This structure highlights a common scaffold from
which novel receptor binding specificities likely evolved. The evolutionary plasticity
of this domain may underlie the diversity of related Envs in circulating viruses.
IMPORTANCE Organisms can access genetic and functional novelty by capturing vi-
ral elements within their genomes, where they can evolve to drive new cellular or
organismal processes. We demonstrate that a retroviral envelope gene, EnvP(b)1, has
been maintained and its fusion activity preserved for 40 to 71 million years. It is ex-
pressed as a protein in multiple healthy human tissues. We determined the structure
of its inferred receptor binding domain and compared it with the same domain in
modern viruses. We found a common conserved architecture that underlies the var-
ied receptor binding activity of divergent Env genes. The modularity and versatility
of this domain may underpin the evolutionary success of this clade of fusogens.
KEYWORDS endogenous retrovirus, envelope protein, paleovirology, structure,
evolution
Integration into nuclear DNA is an obligate step in the retrovirus replicative cycle.Integration events in gamete cells or their progenitor cells can allow viral elements to
be vertically transmitted to offspring. Approximately 8% of the human genome is
derived from such endogenous retroviruses (ERVs), and similar percentages are ob-
served across the animal kingdom (1). Most ERV loci have acquired inactivating
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mutations that erode the coding potential of individual genes and render these loci
incapable of producing infectious viruses. However, some ERV genes can retain their
function in an otherwise degraded provirus, an indication that selective pressures
preserve the function of these genes. Over time, ERV genes can be coopted to perform
beneficial or essential host functions. For example, the cell-cell fusion events that
produce the placental syncytiotrophoblast layer in eutherian mammals are driven by
multiple independently acquired and independently coopted ERV envelopes (Envs),
known as syncytins (2). Primate genomes harbor a number of ERV Env open reading
frames (ORFs) with unknown functions (3, 4). Many of these ORFs have been main-
tained for the duration of primate evolution, time periods exceeding 40 million years.
The human genome contains four copies of ERV-P(b), located on different chromo-
somes; one of these, located within an intron of the RIN3 gene, retains an intact ORF
termed EnvP(b)1 (5). The intact EnvP(b)1 ORF has been identified in Old World primates
and must have arisen as the result of integration of a then-extant virus into the RIN3
locus of a common primate ancestor. The primate EnvP(b)1 ORF is reportedly evolving
under purifying selection, and various dating methods estimate EnvP(b)1 to be be-
tween 30 and 55 million years old (5, 6). EnvP(b)1 has the characteristics of a classical
gammaretroviral envelope protein. All the sequence motifs necessary for processing
and cell surface expression remain intact (5, 7). When ectopically expressed, human
EnvP(b)1 can mediate fusion of cells in culture (7, 8). EnvP(b)1 RNA has been detected
in human tissues; however, protein expression and processing have not been previ-
ously reported (5, 6). It is unclear what function(s) EnvP(b)1 may have that would
explain the fact that it has maintained a functional ORF over tens of millions of years.
Here, we show that EnvP(b)1 protein is expressed in multiple human tissues in a
form that appears to be fusion competent. We establish that EnvP(b)1 is more ancient
than previously reported by identifying orthologs in the RIN3 locus of apes, Old World
monkeys and New World monkeys (simian species). Its absence in the syntenous locus
of prosimian species indicates that EnvP(b)1 was acquired between 40 and 71 million
years ago (MYA). The membrane fusogen activity of EnvP(b)1 has been preserved for
the duration of simian evolution. The host factors required for fusion are conserved and
are ubiquitously expressed in the cultured cells of primates. Thus, an activated, func-
tional, ancient fusogen of unknown function is expressed in multiple healthy human
tissues. We have determined the structure of the EnvP(b)1 inferred receptor binding
domain and compared it with available structures of the homologous domain from
extant retroviruses. Their similarities define a common structural architecture that has
been retained, despite selection for different functions and divergence over timescales
greatly exceeding 40 to 71 million years. Modularity within this domain demonstrates
the flexibility of the architecture of this domain as a versatile scaffold for receptor
binding.
RESULTS
EnvP(b)1 protein is expressed in human tissues. EnvP(b)1 is the only remaining
intact ORF in the ERV-P(b) provirus in the human RIN3 locus, ERV-P(b)1. All other ERV
genes at this locus have been disrupted. We produced a phylogeny to describe the
evolutionary relationships of EnvP(b)1 with other retroviral Envs (Fig. 1A). EnvP(b)1
occupies a clade of viruses that comprises endogenous mammalian and extant avian
examples. Based upon its phylogenetic relationships with other Envs and characteristic
motifs in its surface (SU) and transmembrane (TM) domains, EnvP(b)1 has been classi-
fied as a gamma-type Env (5). Notable elements include an intact furin cleavage site
and a CXXC/CX6CC disulfide bond motif (Fig. 1B).
EnvP(b)1 RNA has previously been detected in human tissues (5, 7). To determine
whether EnvP(b)1 protein is also present, we expressed the genetically unique (no
similar sequences in human or rabbit genomes) inferred receptor binding domain
(iRBD) and used this iRBD protein to immunize a rabbit and produce antiserum. We
enriched for EnvP(b)1 iRBD-binding IgGs with a series of affinity resins and confirmed
by Western blotting that the enriched iRBD antisera detected EnvP(b)1 in transfected
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FIG 1 EnvP(b)1 protein is expressed and processed in human tissues. (A) Maximum-likelihood tree of
retroviral Envs. Full-length amino acid sequences of Envs from five retroviral genera were used as inputs.
The tree is rooted on IAPE (intracisternal A-type particle element with an envelope) Env. Genera of Env
are indicated, as well as the type of Env based on phenotype and sequence (beta type and gamma type).
Daggers indicate sequences that have been found only as endogenous sequences. EnvP(b)1 from human
ERV-P(b) [HERV-P(b)1] is shown in red. The bar shows the scale, in amino acid substitutions per site. (B)
Diagram of mature EnvP(b)1 protein. SU, surface subunit; TM, transmembrane subunit; SP, signal peptide;
(Continued on next page)
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293T cells (Fig. 1C). Two major bands were observed, one corresponding to the
predicted molecular weight of unprocessed EnvP(b)1 SU-TM and a second correspond-
ing to the furin-processed SU domain. The specificity of the SU band was confirmed by
expressing EnvP(b)1 in which the furin cleavage site was mutated [EnvP(b)1CS]. For
this mutant, only the band corresponding to the unprocessed Env was observed. The
reagent is specific for EnvP(b)1, as it failed to detect human syncytin-1 (HERV-W Env),
and Western blots of mock-transfected 293T lysate did not show bands in the appro-
priate locations.
To determine whether EnvP(b)1 protein is expressed in healthy human tissues,
we assayed tissue lysates by Western blotting under reducing conditions (Fig. 1D).
We chose tissues that were similar to those in which RNA transcripts were previ-
ously detected (5, 7). Protein expression was strongest in placenta, ovary, and
thymus. In these tissues, we detected a doublet band for SU that was most
prominent in placenta. This may represent an additional proteolytic processing
event or glycosylation heterogeneity. EnvP(b)1 protein was also detected at lower
levels in testis and small intestine. A band of a different molecular weight was
present in spleen lysate, which we therefore cannot conclude corresponds to
EnvP(b)1 protein. Tissues from both healthy males and females showed clear
EnvP(b)1 expression, indicating that expression is not restricted to females (Ta-
ble S1). We did not observe a higher-molecular-weight species corresponding to
unprocessed SU-TM in any tissue, suggesting that EnvP(b)1 is efficiently processed
in these tissues. In contrast, overexpression of EnvP(b)1 in 293T cells produced
primarily SU-TM (Fig. 1C).
Under nonreducing conditions SU remains covalently linked to TM via a disulfide
bond, and we observed EnvP(b)1 as SU-TM and higher-molecular-weight species
(Fig. S1A). In tissue lysates under nonreducing conditions, EnvP(b)1 was mainly de-
tected as SU-TM and these higher-molecular-weight species (Fig. S1B). In these human
tissues, SU-TM are covalently linked and EnvP(b)1 is likely to be in a state that is primed
for fusion.
EnvP(b)1 ORF is conserved in simian primates. The EnvP(b)1 ORF has been
identified previously in the RIN3 locus of select ape and Old World monkey genomes
(5). We surveyed primate genomes in publicly available databases for the EnvP(b)1 ORF.
We identified 35 orthologs in simian species (New and Old World monkeys and apes).
The presence of each within the RIN3 locus was confirmed by mapping flanking
sequences outside the ERV locus. The phylogenetic relationships between the simian
EnvP(b)1s generally follow the same clustering as their hosts (Fig. 2). This pattern of
branching is consistent with insertion of an ancestral ERVP(b)1 into the RIN3 locus of a
common ancestor of all extant simian primates, followed by divergence of the Env
sequences together with their respective host species. Based on the reported diver-
gence times of New World and Old World monkey lineages (9–11), the EnvP(b)1
insertion arose at least 40 to 47 MYA, considerably earlier than previous synteny-based
estimates (5).
We were unable to identify the EnvP(b)1 ORF in prosimian lineages (tarsiers, lemurs,
and lorisoids). We were also unable to find evidence of the ERV (or solo long terminal
repeat) in prosimian genome assemblies of the RIN3 locus. These observations suggest
that the EnvP(b)1 insertion in simians occurred after their divergence from prosimians
FIG 1 Legend (Continued)
iRBD, inferred receptor binding domain; ISD, immunosuppressive domain; MS, membrane spanning
domain; CT, cytoplasmic tail. The furin cleavage site (RKTR) is noted. (C) Lysates from 293T cells
transfected with the indicated envelope were subjected to Western blotting with either anti-EnvP(b)1
serum or anti-GAPDH antibody. Open arrowheads indicate unprocessed SU-TM. Filled arrowheads
indicate processed SU. (D) Expression of EnvP(b)1 protein in healthy human tissues. Protein lysates from
the indicated tissues from healthy donors were subjected to Western blotting with either anti-EnvP(b)1
sera or anti-GAPDH antibody. A single band corresponding to EnvP(b)1 SU is present in all tissues except
spleen.
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and before the radiation of extant simian species. Bound by these evolutionary events,
the insertion of EnvP(b)1 occurred between 64 to 71 MYA and 40 to 47 MYA (Fig. S2A).
EnvP(b)1-related sequences, of any length or coding capacity, were also absent in all
but one prosimian species, aye-ayes. We identified a number of short reads from an
incomplete genome, which were similar to EnvP(b)1 and the surrounding ERV
(Fig. S2B). These could not be unambiguously assigned to a specific ERV-P(b) locus. How
these sequences entered the aye-aye genome is unknown. Aye-ayes diverged from
other extant lemurs 55 MYA (9–12), shortly after lemurs colonized Madagascar and
became geographically isolated between 55 and 75 MYA (13, 14). EnvP(b)1-related
sequences were also absent in all publicly available databases of mammalian, avian,
reptilian, amphibian, piscine, and insect genomes.
EnvP(b)1 orthologs fuse cells of diverse tissue and species origin. EnvP(b)1 has
evolved under at least three consecutive stages comprising distinctly different selective
pressures: (i) as the Env protein of a circulating virus prior to endogenization, 40 to 71
MYA; (ii) as a captured ERV during the process of cooption by the host; and (iii) as a
gene under purifying selection in all simian species. The fact that the EnvP(b)1 ORF has
been retained throughout simian evolution suggests that it may perform a host
function(s). Expression of human EnvP(b)1 has been shown to drive the formation of
multinucleated syncytia in cultured cells, an indication of cell-cell fusion (7, 8). We
examined the expression, proteolytic processing, and ability to mediate cell-cell fusion
of 11 divergent simian EnvP(b)1 orthologs that were expressed from cells of human,
Old World monkey, and New World monkey origin. All EnvP(b)1s were expressed in all
cell lines, as shown by Western blotting (Fig. S3). Similar to our observations in 293T
cells, and unlike in human tissue lysate, the dominant form of the protein was
unprocessed SU-TM. EnvP(b)1 orthologs from New World monkeys (marmoset and owl
monkey) were detected at lower levels than those from apes and Old World monkeys,
possibly due to sequence differences in the iRBD compared to the human ortholog
FIG 2 Phylogeny of EnvP(b)1 orthologs from the RIN3 locus of simian primates. Maximum-likelihood tree
of all full-length amino acid sequences of EnvP(b)1 ORFs identified from publicly available databases.
Sequences in italics are newly identified in this work. Sequences highlighted in red were used for further
experiments.
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(against which the serum was raised). All 11 EnvP(b)1 orthologs mediated cell-cell
fusion in each of the cell lines tested, with the exception of the pigtail macaque
ortholog in human A549 cells (Fig. 3A and B). Fusion efficiency varied between EnvP(b)1
orthologs and cell lines (Fig. 3B and Fig. S4). EnvP(b)1 from great ape species (human,
chimpanzee, and gorilla) were generally the most fusogenic across all cell lines. In these
assays, the extent of syncytium formation did not correlate with the extent of apparent
EnvP(b)1 expression or processing. Proteolytic processing is essential for fusion, as we
observed complete loss of fusogenicity with a variant of the human EnvP(b)1 ortholog
in which the predicted furin cleavage site was mutated (Fig. 3C).
Structure of the EnvP(b)1 inferred receptor binding domain. We determined the
crystal structure of the human EnvP(b)1 iRBD. Single anomalous dispersion (SAD) from
a platinum derivative was used to obtain experimental phases and ultimately produce
a model (Fig. 4A). The iRBD’s core is defined by a  sandwich that shares some similarity
with a V-type Ig fold, although it lacks the first  sheet at the N terminus. Computa-
tional analysis suggests that the rest of the N-terminal region of EnvP(b)1 is helical and
that it is cleaved by signal peptidase. Extensions between the  sheets form a series of
loops and -helical regions that decorate the core. There is weak sequence identity
between these features and the gammaretrovirus variable regions A, B, and C (VRA,
VRB, and VRC, respectively), which are believed to dictate Env-receptor interactions for
gammaretroviruses (15, 16).
The iRBD is conserved in sequence among the 35 simian EnvP(b)1 orthologs
(Fig. S5), with insertions and deletions present only in the unstructured C terminus. We
mapped amino acid diversity to the iRBD structure by scoring the number of different
amino acids that were present at each position (Fig. 4B). For the majority of the domain,
only one or two amino acids are present at a given site. Substitutions within the core
were often conservative. Most of the sites that tolerate amino acid diversity are in loops
or surface exposed residues on helices. In particular, the sequence of VRC has diverged
FIG 3 EnvP(b)1 fusogenicity has been maintained over the course of simian evolution. (A) Representative fusion assays performed in Vero
(green monkey) cells. Cells were transfected with EnvP(b)1 ORFs from the indicated species, allowed to fuse, fixed, and later stained with
nuclear stain (blue) prior to imaging. Arrows indicate multinucleated syncytia arising from EnvP(b)1-mediated cell fusion. Bar, 100 m. (B)
Summary of the relative fusogenicity of simian EnvP(b)1 orthologs expressed in cells from divergent simian species. Fusogenicity of each
EnvP(b)1 in each cell was determined by approximating the percentage of total cells fused under each condition. , 1 to 25%; , 26
to 50%; , 51 to 75%; , 75 to 100%. Cell line species: A549, human (ape); Vero, green monkey (Old World monkey); LLC-MK2,
macaque (Old World monkey); OMK, owl monkey (New World monkey). AGM, African green monkey; Mac, macaque. (C) A furin cleavage
site mutant does not fuse cells. Vero cells were transfected with human EnvP(b)1, human EnvP(b)1cs, or empty vector. Arrows indicate
syncytia. Bar, 100 m.
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FIG 4 Structure of the EnvP(b)1 inferred receptor binding domain (iRBD). (A) Crystal structure of
EnvP(b)1 iRBD. A C-terminal tag that is present in the structure was removed in this representation. A
single glycan, resolved in the structure, is also not shown. Variable regions (VRA, VRB, and VRC), the
8-amino-acid loop, and the central helix are annotated. (B) Amino acid diversity of the simian EnvP(b)1
iRBD. Amino acid diversity was compared between 35 simian EnvP(b)1 iRBD sequences. Each residue is
colored based on the number of unique amino acids found at that position. (C) Comparison of EnvP(b)1
iRBD with RBD structures of extant gammaretroviruses. (Top) EnvP(b)1 (red) overlaid with FrMLV (purple)
(PDB code 1AOL). (Middle) EnvP(b)1 overlaid with FeLV (blue) (PDB code 1LCS). (Bottom) Overlay of all
(Continued on next page)
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the most rapidly, suggesting that its sequence is not subject to the same constraints as
other regions of the iRBD.
We compared the iRBD structure to the two other known gammaretrovirus RBD
structures. These are from Friend murine leukemia virus (FrMLV) and feline leukemia
virus (FeLV), both extant circulating viruses (15, 17). The iRBD shares little (20%)
sequence identity with these examples, yet it shows extremely strong structural
similarities. The EnvP(b)1 iRBD is more compact with shorter, less prominent loop
structures extending from its core (Fig. 4C). All three VRs are shorter in EnvP(b)1: VRA
and VRB are dramatically shorter, and the VRC, also shorter, adopts a different confor-
mation as it is liberated from constraints by the absence of the paired Cys residues that
form a disulfide in FrMLV and FeLV. Additional connecting regions also exhibit changes
in length and corresponding structural differences. As a consequence, the potential
receptor-interacting interfaces of EnvP(b)1 are quite different from those for FrMLV and
FeLV. However, there is clearly a structurally conserved architecture that is common
among gammaretroviruses (Fig. S6). The  sandwich core, a central helix that runs
perpendicular to it, and an 8-amino-acid loop between the last two  sheets are all
structurally conserved. This conserved scaffold structure serves as a platform for the
presentation of unique elements that determine receptor binding specificity.
DISCUSSION
Captured viral diversity has produced host genetic novelty. Viral Env proteins have
at least two activities: receptor binding and membrane fusion. In cells, Env-receptor
interactions can result in receptor blockade or downregulation of the receptor from the
cell surface. Receptor engagement is also often a trigger that potentiates membrane
fusion. Over the course of animal evolution, these viral functions have been coopted in
multiple instances to perform host functions. ERV Envs that have been coopted are
diverse in their ages, sequences, and, where known, binding partners (18). It appears
that capturing and maintaining a variety of genes from divergent viruses provides
evolutionary benefits.
EnvP(b)1 has all the hallmarks of a viral fusogen that has been repurposed to
perform a host function. In contrast to other ERV-P(b)1 genes, the EnvP(b)1 ORF has
been maintained as a coopted gene for the entirety of simian evolution, and likely
longer. At least one of its functions, membrane fusion, has also been retained in every
simian clade. Syncytin-2 (ERV-FRD Env), which is thought to play a key role in the
formation of the syncytiotrophoblast layer of the placenta, is the only other ERV Env
known to have fusogenic members in all simian clades (19–21). Our transfection and
fusion experiments, performed in cells derived from divergent primate species, indicate
that the unidentified cellular factors required for fusion, such as receptors and pro-
teases, are also conserved. In these assays, ape and New World monkey EnvP(b)1
orthologs tended to behave more similarly to each other, while Old World monkey
EnvP(b)1s were overall less fusogenic. These lineage-specific differences may reflect the
consequences of divergence and coevolution of EnvP(b)1 orthologs with the factors
that are required for cell fusion.
EnvP(b)1 protein is expressed in multiple healthy human tissues. In these tissues, it
exists in a processed, presumably fusion-competent form. We detected the fully
processed SU form and no unprocessed SU-TM in all EnvP(b)1-expressing tissues. In
contrast, SU-TM was the major species in transfected cells. We speculate that in tissues,
expression of EnvP(b)1 and the proper furin-like protease may be coordinated. Under
nonreducing conditions, EnvP(b)1 is predominantly found in higher-molecular-weight
species in both tissues and transfected cells, similar to oligomeric species observed for
syncytin-1 (ERV-W Env) under nonreducing conditions (22, 23), indicating that disulfide-
linked and fusion-primed SU-TM is present in these tissues. Our detection of protein
FIG 4 Legend (Continued)
three RBD structures. Common features of the beta sheet core, central helix, and 8-amino-acid loop are
highlighted in yellow on the EnvP(b)1 structure.
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was generally in agreement with the previously reported RNA abundances, with the
exception of splenic tissue, where we observed only a band of a different molecular
weight (5, 7). Placental tissue had the highest expression of EnvP(b)1 protein. In other
tissues, expression did not vary with pregnancy or gender. The function of EnvP(b)1 is
unknown, but its maintenance among simians for at least 40 to 71 million years and its
expression and processing in human tissues indicate that it must in some way con-
tribute to an important physiological process, likely involving membrane fusion.
Among human examples, selective preservation or loss of furin processing has
accompanied cooption. The two syncytins are activated by furin-like cleavage events
and act as membrane fusogens (2). HERV-T is no longer processed, is not fusogenic, and
has evolved to downregulate its receptor (24). HEMO, of unknown function, is not
classically processed by proteases but has evolved to be shed from cells via an
alternative cleavage event (25). Others, like recently integrated HERV-K copies, may
have been too recently acquired to have gained or lost functions. EnvP(b)1 has clearly
evolved to retain its processing and fusogenicity.
EnvP(b)1 and the original infectious progenitor virus are quite ancient. We have
determined that the EnvP(b)1 ORF has been maintained within the RIN3 locus for the
duration of simian primate evolution. Insertion into this locus occurred after the
divergence of simians from prosimians and before the radiation of extant simian
species, or between 71 and 40 million years ago. One study, using LTR dating ap-
proaches, has estimated ERV-P(b)1 to be as old as 55 million years (6). We identified a
number of related sequences in the genome of an aye-aye, a species which has evolved
in isolation on Madagascar for the past 55 to 75 million years (13, 14). Due to their short
length and an incomplete aye-aye genome, we cannot resolve the relationship of these
sequences with EnvP(b)1 or other related loci in simian genomes. Nonetheless, it
appears likely that interactions between primates and related circulating virus are
ancient and were widely distributed.
EnvP(b)1 has been preserved in simian genomes for at least 40 to 71 million years
of evolution. We determined a structure of the iRBD from this ancient viral element. The
iRBD amino acid sequence is largely conserved among the EnvP(b)1 loci found in host
genomes. Though the EnvP(b)1 ORF as a whole is under purifying selection, some
diversity has accumulated in the variable regions. These sites evolve rapidly in
circulating viruses, and their divergence in EnvP(b)1 indicates that such sites can
tolerate substitution without compromising function even in the context of a
coopted protein. This conservation and the lack of insertions/deletions suggest that
the current iRBD may closely approximate that of the infectious progenitor virus
that circulated 40 to 71 MYA.
Comparisons with RBD structures from two extant gammaretroviruses highlight the
exquisite evolutionary plasticity of this domain. All three share a conserved architecture
that depends little on sequence conservation. Upon this common scaffold, each Env
has evolved a series of unique features. EnvP(b)1 is the most compact, while the cores
of FeLV and Fr-MLV are decorated by large structured extensions. The lack of sequence
conservation prevents us from tracing the origins of these features. Whether the
elaborate elements reflect a consequence of ongoing virus-host evolution (e.g., anti-
body escape or receptor evolution) over timescales greatly exceeding 40 to 71 million
years or whether contemporary Envs retain RBD domains that are equivalently compact
can only be resolved through additional structures. It does, however, underscore the
versatility of this fold as a platform for recognizing many different receptor molecules.
This versatility in receptor recognition may underlie the evolutionary success of gam-
maretroviruses, and of the Env proteins themselves, as evidenced by their wide
distribution as viral fusogens, ERV elements, and coopted genes.
MATERIALS AND METHODS
Cell lines. Human 293F cells were maintained at 37°C with 5% CO2 in FreeStyle 293 expression
medium (Thermo Fisher) supplemented with penicillin and streptomycin. Human 293T (ATCC CRL-3216;
American Type Culture Collection), green monkey Vero (ATCC CCL-81), and rhesus macaque LLC-MK2
(ATCC CCL-7) cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
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fetal bovine serum (FBS) and maintained at 37°C and 5% CO2. Owl monkey OMK cells (ATCC CRL-1556)
were grown in Eagle’s minimum essential medium (EMEM) supplemented with 10% FBS and maintained
at 37°C and 5% CO2.
Identification of EnvP(b)1 sequences. Human, chimpanzee, white-cheeked gibbon, African green
monkey, and pigtail macaque sequences were previously published (5). All other full-length EnvP(b)1
ORFs were identified through querying publicly available databases, including NCBI GenBank, Ensmbl,
and the UCSC genome browser, using the full-length human EnvP(b)1 nucleotide sequence. Databases
queried included fully assembled genomes, NCBI nucleotide database, and whole-genome shotgun
reads identified through the basic local alignment tool (BLAST). Details of these sequences are shown in
Table S2.
Sequences mapping to the ERV-P(b) provirus in the aye-aye genome were identified through BLAST
using either the SU domain of human EnvP(b)1 or the entire human ERV-P(b)1 locus, querying whole-
genome shotgun sequences from Daubentonia madagascariensis (aye-aye). Eleven reads were identified
that mapped to ERV-P(b) from an unassembled aye-aye genome (26). Accession numbers for these reads
are AGTM011455045, AGTM012725663, AGTM010332352.1, AGTM011595709.1, AGTM012840819.1,
AGTM011264183.1, AGTM012908686, AGTM010255092, AGTM010981769, AGTM011358766, and
AGTM010685344.
Plasmids. Human EnvP(b)1 codon-optimized sequence was ordered from GenScript. EnvP(b)1
sequences from chimpanzee, white-cheeked gibbon, gorilla, African green monkey, pigtail macaque,
crab-eating macaque, sooty mangabey, baboon, common marmoset, and owl monkey were ordered
from Genewiz. All sequences were cloned into a modified version of pVRC-8400 expression vector (27).
EnvP(b)1CS with the furin cleavage site mutated from RKTR to SKTR was generated from the human
EnvP(b)1 plasmid using QuikChange site-directed mutagenesis (Agilent). EnvP(b)1 iRBD sequences were
synthesized and cloned into a modified pVRC8400 expression vector, as previously described (28, 29).
Recombinant EnvP(b)1 iRBD expression and purification. The inferred receptor binding domain,
residues 51 to 210, of human EnvP(b)1, was deduced as follows. A region of homology to murine and
feline leukemia virus RBDs was identified using the Phyre2 server (30). The signal peptide cleavage site
was predicted using the SignalP-4.1 server (31) and Phyre2 secondary structure prediction (30). This
defined the iRBD N terminus. The C-terminal boundary was defined by the transition from a predicted
unstructured region to the proline-rich region. iRBDs were synthesized and cloned into a modified
pVRC8400 mammalian expression vector. We produced a variant with a C-terminal human rhinovirus 3C
protease cleavage site followed by a 6His tag and a variant with the following C-terminal tag
configuration: an HA-tag followed by a rhinovirus 3C protease cleavage site, an 8His tag, and a 6His
tag. Short Gly-Gly-Ala linkers separate the HA, 3C, and poly-His tags. iRBD variants were produced by
polyethylenimine (PEI)-facilitated transient transfection of 293F cells that were maintained in FreeStyle
293 expression medium. Transfection complexes were prepared in Opti-MEM and added to cells.
Supernatants were harvested 4 to 5 days posttransfection and clarified by low-speed centrifugation.
iRBDs were purified by passage over cobalt-nitrilotriacetic acid (Co-NTA) agarose (Clontech) followed by
gel filtration chromatography on Superdex 200 (GE Healthcare) in 10 mM Tris-HCl, 150 mM NaCl at pH 7.5
(buffer A).
For immunization of rabbits and production of antisera enriched for iRBD-directed IgGs, we used the
version with the 3C protease site and 6His tag. Both were removed by treatment with PreScission
protease (MolBioTech; ThermoScientific). The protein was repurified on Co-NTA agarose followed by gel
filtration chromatography on Superdex 200 (GE Healthcare) in buffer A to remove the protease, tag, and
uncleaved protein. Crystallographic studies used the hemagglutinin (HA)-tagged version, which was not
treated with protease to remove its poly-His tags.
Generation and enrichment of EnvP(b)1 iRBD-specific antisera. Bulk anti-iRBD serum was gen-
erated by Covance. Purified recombinant EnvP(b)1 iRBD was used to immunize a single rabbit. Serum
from the terminal bleed was tested for detection of EnvP(b)1 by Western blot. Crude rabbit serum was
diluted 1:50 in buffer A. Bulk IgGs were captured by protein A agarose resin (GoldBio) at 4°C with rotating
overnight. The resin was collected in a chromatography column, washed with a column volume of buffer
A, and eluted with 0.1 M glycine buffer (pH 2.5), which was immediately neutralized by 1 M Tris (pH 8.0).
Antibodies were then dialyzed against phosphate-buffered saline (PBS) (pH 7.4). To produce an EnvP(b)1
iRBD affinity resin, EnvP(b)1 was expressed and purified as described above. Cleaved iRBD was then
concentrated, dialyzed against phosphate-buffered saline (PBS) (pH 7.4), and arrested to Pierce
N-hydroxysuccinimide (NHS)-activated agarose beads per the manufacturer’s protocol. The reaction was
then quenched by the addition of Tris (pH 7.5). Rabbit antibodies were then incubated with the iRBD
resin at 4°C with rotating overnight. The iRBD resin was collected in a chromatography column, washed
with a column volume of PBS (pH 7.4), and eluted with 0.1 M glycine buffer (pH 2.5), which was
immediately neutralized by 1 M Tris (pH 8.0). Antibodies were then dialyzed against PBS (pH 7.4).
Crystallization, structure determination, and refinement. EnvP(b)1 iRBD, with its one native
N-linked glycan and a C-terminal tag, was concentrated to 10 to 12 mg/ml. Crystals were grown in
hanging drops over a reservoir of 0.5 M sodium chloride, 0.1 M bis-Tris propane (pH 7.0), 20% (wt/vol)
polyethylene glycol 4000. Platinum was incorporated by incubating crystals in a solution of 0.08 M
bis-Tris propane, 0.4 M sodium formate, 16% (wt/vol) polyethylene glycol 4000, and 10 mM potassium
tetrachloroplatinate(II) for approximately 48 h. All crystals were cryoprotected in 22 to 25% (vol/vol)
glycerol. We recorded diffraction data at the Advanced Light Source on beamline 8.2.2 and on the
Advanced Photon Source on beamlines 24-ID-E and 24-ID-C.
Using XDS (32), data were processed for one native crystal and the single anomalous dispersion (SAD)
data were obtained for one platinum derivative crystal. The merged data used for phasing had an
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anomalous signal to about 3.5 Å resolution. Using SHELX (33), we found 5 platinum sites, refined them,
and calculated phase probabilities. Initial maps were obtained after statistical density modification using
RESOLVE (34). The Matthew coefficient suggested that there were multiple iRBD copies in the asymmetric
unit. We flooded the initial map with dummy atoms and carved out a single copy of iRBD (the one with
the best-resolved density) by inspection in PyMol (Schrödinger, LLC). With this we obtained a search
model to locate two additional copies of iRBD in the asymmetric unit by molecular replacement using
PHASER (35). After further optimizing the phases by 3-fold noncrystallographic symmetry (NCS) averag-
ing, we obtained a map of reasonable quality to build an initial model that was then used to phase the
native data set.
We carried out refinement calculations with PHENIX (36) and model modifications with COOT (37).
Refinement of atomic positions and B factors was followed by translation-liberation-screw (TLS) param-
eterization and placement of water molecules. Final coordinates were validated with the MolProbity
server (38). Data collection and refinement statistics are in Table S3. Figures were made with PyMol.
Comparison of RBD structures. Topology diagrams of the EnvP(b)1 iRBD, Friend murine leukemia
virus RBD (PDB code 1LCS) (15), and feline leukemia virus RBD (PDB code 1AOL) (17) were modified from
those created by PDBSum (39). We used the Dali protein structure comparison server (40) to determine
the percent identity, root mean square deviation (RMSD), and DALI Z-scores for these three proteins.
Human tissue lysates and cell lysate Western blots. Tissue protein lysates were purchased from
TaKaRa. Details for each lysate are shown in Table S1. Tissue lysate was mixed with Laemmli buffer with
or without (for nonreducing conditions) 2-mercaptoethanol and boiled for 5 min. A 40-g portion of
tissue lysate was run on a 4 to 20% acrylamide gel (Bio-Rad).
Human EnvP(b)1, EnvP(b)1cs, HERV-W Env, and empty vector were transfected into 293T cells using
Lipofectamine 3000 reagent (Life Technologies). Human, chimpanzee, gorilla, gibbon, African green
monkey, pigtail macaque, sooty mangabey, baboon, crab-eating macaque, owl monkey, and marmoset
EnvP(b)1 plasmids were transfected into A549, Vero, LLC-MK2, and OMK cells using Lipofectamine 3000
reagent. At 24 h posttransfection, cells were lysed in TNE buffer (50 mM Tris, 2 mM EDTA, 150 mM NaCl)
supplemented with 1% Triton X-100. Lysates were boiled in Laemmli buffer with or without (for
nonreducing condition for A549 lysate) 2-mercaptoethanol and run on 4 to 20% acrylamide gels.
For all Western blots, proteins were transferred onto nitrocellulose membrane. Membranes were
blocked with 5% milk in PBS– 0.1% Tween 20 and probed with anti-EnvP(b)1 serum or mouse anti-GAPDH
antibody (Genscript), followed by horseradish peroxidase (HRP)-conjugated goat anti-mouse immuno-
globulin (Invitrogen) or HRP-conjugated goat anti-rabbit immunoglobulin (Sigma-Aldrich) antibodies.
Membranes were incubated with enhanced chemiluminescence (ECL) reagent (Thermo), and signal was
detected using an Amersham imager 600 device (GE Healthcare). Images were processed using ImageJ
software (National Institutes of Health).
Cell-cell fusion. Human, chimpanzee, gorilla, gibbon, African green monkey, pigtail macaque, sooty
mangabey, baboon, crab-eating macaque, owl monkey, and marmoset EnvP(b)1 plasmids were trans-
fected into A549, Vero, LLC-MK2, and OMK cells using Lipofectamine 3000 reagent. At 18 to 24 h
posttransfection, cells were stained with NucBlue live cell nuclear stain (Life Technologies) for 20 min at
37°C and subsequently imaged. Images were processed using ImageJ software.
Data availability. Coordinates and diffraction data have been deposited at the Protein Data Bank
(PDB code 6W5Y).
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